IP Library Granted Patent US 8,809,508
Granted Patent B2
US 8,809,508 · App. 13/422,583 · Granted Aug 19, 2014

Diagnostic antibody assay

Inventors: Martin Kleinschmidt (Halle/Saale, DE); Stephan Schilling (Halle/Saale, DE); Jens-Ulrich Rahfeld (Gemeinde Seegebiet Mansfelder Land, DE); Kristin Ebermann (Zittau, DE); Hans-Ulrich Demuth (Halle/Saale, DE)
Assignee: Probiodrug AG
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,809,508
App. No.
13/422,583
Granted
Aug 19, 2014
Kind
B2
Abstract

Diagnostic assays for the diagnosis of amyloidosis, in particular Alzheimer's disease, and related aspects. In particular, monoclonal antibodies and an antibody assay are provided.

Claims (17)

1. An isolated monoclonal antibody that binds to AβpGlu(11) peptides or variants thereof, wherein

said antibody has a dissociation constant (K D ) value of 10 −7 M or less; and

the variable part of the light chain of said antibody is encoded by a nucleic acid molecule having the nucleotide sequence of SEQ ID NO: 51 or has the amino acid sequence of SEQ ID NO: 52.

2. The antibody according to claim 1 , wherein said antibody is Aβ 13-11-6 (Deposit No. DSM ACC 3100).

3. The antibody according to claim 1 , wherein the antibody is a labeled antibody.

4. The antibody according to claim 1 , wherein the antibody is immobilized on a solid phase.

5. An isolated monoclonal antibody that binds to AβpGlu(11) peptides or variants thereof, wherein:

said antibody has a dissociation constant (K D ) value of 10 −7 M or less, and

the variable part of the heavy chain of said antibody is encoded by a nucleic acid molecule having the nucleotide sequence of SEQ ID NO: 53 or has the amino acid sequence of SEQ ID NO: 54.

6. The antibody according to claim 5 , wherein said antibody is Aβ 13-11-6 (Deposit No. DSM ACC 3100).

7. An isolated monoclonal antibody that binds to AβpGlu(11) peptides or variants thereof, wherein:

said antibody has a dissociation constant (K D ) value of 10 −7 M or less,

the variable part of the light chain of said antibody is encoded by a nucleic acid molecule having the nucleotide sequence of SEQ ID NO: 51 or has the amino acid sequence of SEQ ID NO: 52, and

the variable part of the heavy chain of said antibody is encoded by a nucleic acid molecule having the nucleotide sequence of SEQ ID NO: 53 or has the amino acid sequence of SEQ ID NO: 54.

8. The antibody according to claim 7 , wherein said antibody is Aβ 13-11-6 (Deposit No. DSM ACC 3100).

9. An antibody obtainable from the hybridoma cell line DSM ACC 3100.

10. A hybridoma cell line DSM ACC 3100.

Assignments (3)
CHANGE OF NAME Recorded Oct 27, 2021
From: PROBIODRUG AG
To: VIVORYON THERAPEUTICS AG
Reel/Frame 057928/0117 →
CHANGE OF NAME Recorded Oct 27, 2021
From: VIVORYON THERAPEUTICS AG
To: VIVORYON THERAPEUTICS N.V.
Reel/Frame 058250/0641 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 18, 2012
From: KLEINSCHMIDT, MARTIN; SCHILLING, STEPHAN; RAHFELD, JENS-ULRICH; EBERMANN, KRISTIN; DEMUTH, HANS-ULRICH
To: PROBIODRUG AG
Reel/Frame 028234/0567 →
Continuity (2)
Provisional Application 61453449 · Mar 16, 2011
Related Publication 20120237529A1 · Sep 20, 2012